Cargando…
Molecular docking analysis of KRAS inhibitors for cancer management
The majority of human tumors are characterized by abnormal signaling caused by oncogenic RAS proteins. KRAS is a member of the RAS family and is currently one of the most thoroughly researched targets for cancer treatment due to its prevalence in a variety of deadly malignancies. Targeting the KRAS...
Autores principales: | J. Hakeem, Israa, Alsharif, Fatmah Hazza, Aljadani, Majidah, Fahad Alabbas, Ibrahim, Faqihi, Mohammed Saud, Aloufi, Ahmed Hamdan, Almutairi, Wael Abdullah, Akber, Asif Hussain, Alam, Qamre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Biomedical Informatics
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10563554/ https://www.ncbi.nlm.nih.gov/pubmed/37822837 http://dx.doi.org/10.6026/97320630019411 |
Ejemplares similares
-
Molecular docking analysis of MCL-1 inhibitors for breast cancer management
por: Abdulrahman, Alzahrani, et al.
Publicado: (2023) -
Insights from the molecular docking analysis of EGFR antagonists
por: Kamal, Mohammad Azhar, et al.
Publicado: (2023) -
Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management
por: Hakeem, Israa J
Publicado: (2023) -
Molecular docking analysis of HER-2 inhibitor from the ZINC database as anticancer agents
por: Sait, Khalid Hussain Wali, et al.
Publicado: (2020) -
Evaluation of Sleep Behavior and the Use of Sleep Aids among Adults Living in Saudi Arabia: A Cross-Sectional Study
por: Aldhafiri, Ahmed, et al.
Publicado: (2023)